I see no point answering , when all that happens is a slur fest , all I wanteed was to chat to Ip about valuations .
I never created the link between Befesa and SSC , I simply granted that it was agreed previously as I have seen it mentioned many times , Super mentioned it to discredit befesa I granted it .
Befesa is in the US , has bought a buisness there , wants to grow there , but as I read it as yet have not won a tender or signed a deal as on salt slag.
Same as MHN they both state this is an objective
Rather than argue .take a read of the annual report of a key competitor
My question was a negative , ie trying to understand how in this division they can have 700e revenue yet just 8% odd net profit when MHM hopes to have far different retruns on its revenue
On the positve side if you read the report on Befesa you can see they have fingers in heaps of pies , so MHM have the ability to sneak under their guard and steal a march
in this US market
Europe looks like theirs as they have 50% already
If MHM do get geelong up and running , sign a deal with Tennessee , mhm makes a very nice target for befesa as it appears to be owned by a great business with huge revenue , income dividends and history of taking over companies as they did with befesa in 2010 .
Good reading and I am sure MHN shareholders will get more positives than negatives reading about this 2 billion euro business
www,abengoa.es
- Forums
- ASX - By Stock
- VYS
- research & resulting questions
research & resulting questions, page-62
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VYS (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.0¢ |
Change
-0.015(3.70%) |
Mkt cap ! $163.2M |
Open | High | Low | Value | Volume |
40.0¢ | 40.0¢ | 37.5¢ | $49.87K | 127.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49855 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 14789 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49855 | 0.375 |
4 | 116863 | 0.370 |
1 | 9534 | 0.365 |
3 | 42888 | 0.360 |
2 | 16500 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 14789 | 1 |
0.400 | 17991 | 1 |
0.410 | 289026 | 2 |
0.420 | 179647 | 5 |
0.425 | 424858 | 4 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
VYS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online